# A Clinical Study to Measure the Effect of OP-101 After Being Administered Subcutaneous in Healthy Volunteers

> **NCT04321980** · PHASE1 · COMPLETED · sponsor: **Orpheris, Inc.** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** OP-101

## Key facts

- **NCT ID:** NCT04321980
- **Lead sponsor:** Orpheris, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-19
- **Primary completion:** 2020-05-22
- **Final completion:** 2020-05-22
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2021-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04321980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04321980, "A Clinical Study to Measure the Effect of OP-101 After Being Administered Subcutaneous in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04321980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*